Apexion Health Testosterone Cypionate treatment vial
HORMONETRT

MONTHLY SUPPLY · 100–200MG/WEEK

TESTOSTERONE

TREATMENT

Restore energy, drive, and lean muscle mass

SUPPORT

Testosterone cypionate is a long-acting bioidentical testosterone ester that restores physiological hormone levels in men with clinical hypogonadism under physician supervision.

Shop Now

Lab-Tested · Physician-Supervised · Discreet Delivery

Apexion Health — HORMONE

YOUR TESTOSTERONE. RESTORED.

Testosterone peaks in early adulthood and declines approximately 1% per year after 30. By 50, many men have levels 30–50% lower than their peak. The symptoms are familiar: fatigue, reduced libido, difficulty maintaining muscle, and mood changes. Testosterone replacement therapy with physician monitoring addresses the root cause directly.

Clinical Benefits

TESTOSTERONE SUPPORTS YOUR HEALTH AT THE CELLULAR LEVEL

  1. 01.

    RESTORES ENERGY, VITALITY, AND PHYSICAL DRIVE

  2. 02.

    SUPPORTS LEAN MUSCLE MASS AND STRENGTH

  3. 03.

    IMPROVES MOOD, MOTIVATION, AND COGNITIVE CLARITY

  4. 04.

    REDUCES BODY FAT IN CONJUNCTION WITH LIFESTYLE

  5. 05.

    SUPPORTS BONE DENSITY AND LONG-TERM SKELETAL HEALTH

  6. 06.

    PHYSICIAN-MONITORED WITH REGULAR LAB PANEL REVIEW

Shop Now

Clinical Evidence

How It Works in the Body

01 — Dose & Efficacy

Testosterone Restoration

Lean Mass +2–3 kg over 6 months40%
Fat Mass −2 to −3 kg over 6 months30%
Sexual Function Improved in ~60% of men60%

Bhasin et al., NEJM 1996; Endocrine Society CPG 2018

02 — Hormone Panel

Hormone & Safety Markers

MarkerWithoutWith Treatment
Total Tng/dL
250
600+350
Free Tpg/mL
45
120+75
SHBGnmol/L
30
28−2
Hematocrit%
43.0
47.5+4.5

Hematocrit is the critical safety marker

TRT increases Hct 3–6 percentage points. >54% increases thrombotic risk — requires dose reduction or phlebotomy. Monitor at 3, 6, 12 months, then annually.

Bhasin et al., NEJM 1996; Endocrine Society CPG 2018

03 — Protocol

TRT Initiation & Monitoring

BaselinePre-treatment
  • Total T (2× AM, 8–10 AM draw)
  • Free T, SHBG
  • PSA, Hct, lipids, LFTs
Titration3–6 months
  • 100–200 mg IM q1–2 weeks
  • Trough T at 3 months
  • Hct & PSA at 3 & 6 months
MaintenanceAnnual
  • Total T & free T trough
  • Hematocrit & PSA
  • DEXA if indicated

Goal: mid-normal range (400–700 ng/dL trough)

Trough drawn immediately before next injection. Adjust dose based on 3-month trough. If Hct >52%, reduce dose. If >54%, hold TRT, consider phlebotomy.

All protocols physician-supervised and adjusted per individual labs.